Israel Englander Amryt Pharma PLC Transaction History

Millennium Management LLC

  • $207 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$7.0 - $14.77 $1.69 Million - $3.57 Million
241,968 Added 174.84%
380,359 $5.55 Million
Q4 2022

Feb 14, 2023
SELL
$6.68 - $7.58 $806,509 - $915,171
-120,735 Reduced 46.59%
138,391 $1.01 Million
Q3 2022

Nov 14, 2022
BUY
$6.8 - $8.01 $146,322 - $172,359
21,518 Added 9.06%
259,126 $1.79 Million

Others Institutions Holding AMYT

# of Institutions
5
Shares Held
142K
Call Options Held
0
Put Options Held
0
View Full List

About Amryt Pharma plc

AMYT Quotes by TradingView
  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email